Literature DB >> 15573240

Current use of thromboembolism prophylaxis for laparoscopic cholecystectomy patients in Sweden.

F Lindberg1, M Bjorck, I Rasmussen, D Bergqvist.   

Abstract

BACKGROUND: The need for thromboembolism (TE) prophylaxis during laparoscopic surgery is not well established. The aim of this study was to investigate current TE prophylaxis in patients undergoing laparoscopic cholecystectomy (LC) in Sweden.
METHODS: Mail questionnaire to all Surgical Departments in Sweden about the current use of thromboembolism prophylaxis in patients undergoing laparoscopic cholecystectomy.
RESULTS: The response rate was 78 of 80 departments of surgery (98%). Seventy reported performing LC. Thirty-six percent used thromboembolism prophylaxis in all patients, 17% in most, 9% in half their patients and 39% only rarely. The current use of thromboembolism prophylaxis ranged from low-molecular-weight heparin for 7 days + stockings in all patients to no prophylaxis at all in the majority of patients.
CONCLUSIONS: The use of thromboembolism prophylaxis in LC patients is highly variable, even in the small and homogenous country of Sweden. Further studies concerning the risk of TE complications after laparoscopic surgery are warranted.

Entities:  

Mesh:

Year:  2004        PMID: 15573240     DOI: 10.1007/s00464-004-9095-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  22 in total

1.  Antithrombotic prophylaxis in patients undergoing laparoscopic cholecystectomy.

Authors:  H Bounameaux; D Didier; O Polat; S Desmarais; P de Moerloose; O Huber
Journal:  Thromb Res       Date:  1997-05-01       Impact factor: 3.944

2.  Survey of the use of thromboprophylaxis in laparoscopic surgery in Denmark.

Authors:  T Filtenborg Tvedskov; M S Rasmussen; P Wille-Jørgensen
Journal:  Br J Surg       Date:  2001-10       Impact factor: 6.939

3.  The cost-effectiveness of prevention of post-operative thromboembolism.

Authors:  D Bergqvist; T Mätzsch; S Jendteg; B Lindgren; U Persson
Journal:  Acta Chir Scand Suppl       Date:  1990

4.  Thromboembolism prophylaxis during laparoscopic cholecystectomy.

Authors:  A W Bradbury; Y C Chan; A Darzi; G Stansby
Journal:  Br J Surg       Date:  1997-07       Impact factor: 6.939

5.  Deep venous thrombosis after laparoscopic cholecystectomy and prevention with nadroparin.

Authors:  J T H Schaepkens Van Riempst; R H G G Van Hee; J J J Weyler
Journal:  Surg Endosc       Date:  2001-10-05       Impact factor: 4.584

Review 6.  Pharmacology of low molecular weight heparins.

Authors:  K Kleinschmidt; R Charles
Journal:  Emerg Med Clin North Am       Date:  2001-11       Impact factor: 2.264

7.  [Risk factors and prevention of thromboembolic risk in laparoscopy].

Authors:  J M Catheline; J L Gaillard; N Rizk; C Barrat; G Champault
Journal:  Ann Chir       Date:  1998

Review 8.  Prevention of postoperative venous thromboembolism following laparoscopic cholecystectomy.

Authors:  J A Caprini; J I Arcelus
Journal:  Surg Endosc       Date:  1994-07       Impact factor: 4.584

9.  Incidence of deep vein thrombosis after laparoscopic vs minilaparotomy cholecystectomy.

Authors:  R V Lord; J J Ling; T B Hugh; M J Coleman; B D Doust; I Nivison-Smith
Journal:  Arch Surg       Date:  1998-09

10.  Deep venous thrombosis prophylaxis is not indicated for laparoscopic cholecystectomy.

Authors:  A M Blake; S I Toker; E Dunn
Journal:  JSLS       Date:  2001 Jul-Sep       Impact factor: 2.172

View more
  1 in total

1.  Incidence and risk factors for symptomatic venous thromboembolism following cholecystectomy.

Authors:  J Strömberg; O Sadr-Azodi; P Videhult; F Hammarqvist; G Sandblom
Journal:  Langenbecks Arch Surg       Date:  2015-02-15       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.